Minghui Wang Selected Research

Triple Negative Breast Neoplasms

1/2018	EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy.
11/2016	DGCA: A comprehensive R package for Differential Gene Correlation Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minghui Wang Research Topics

Disease

90	Neoplasms (Cancer) 04/2024 - 03/2002
17	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 11/2018
16	Infections 11/2023 - 12/2002
13	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 08/2002
11	Esophageal Squamous Cell Carcinoma 01/2024 - 01/2013
11	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2016
11	Breast Neoplasms (Breast Cancer) 06/2023 - 01/2005
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2012
7	Fibrosis (Cirrhosis) 01/2024 - 10/2002
7	Neuroinflammatory Diseases 08/2023 - 01/2019
6	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2013
6	Adenocarcinoma of Lung 10/2023 - 02/2016
6	Carcinogenesis 10/2023 - 01/2013
6	Carcinoma (Carcinomatosis) 01/2021 - 01/2008
5	Hemorrhage 11/2023 - 06/2021
5	Amyloid Plaque 11/2023 - 11/2017
5	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 04/2009
3	Obesity 03/2024 - 01/2020
3	Allergic Rhinitis 01/2024 - 01/2023
3	Pain (Aches) 11/2023 - 01/2020
3	Hypersplenism (Anemia, Splenic) 11/2023 - 06/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 10/2003
3	Melanoma (Melanoma, Malignant) 10/2023 - 04/2004
3	Inflammation (Inflammations) 10/2023 - 01/2020
3	Brain Neoplasms (Brain Tumor) 09/2023 - 04/2006
3	Pathologic Processes 07/2023 - 01/2022
3	Atherosclerosis 01/2023 - 12/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2014
3	Hypertrophy 01/2023 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 06/2018
3	Glioma (Gliomas) 08/2022 - 04/2006
3	Adenocarcinoma 01/2022 - 01/2014
3	Bacterial Infections (Bacterial Infection) 12/2020 - 12/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2011
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2004 - 08/2004
2	Disease Progression 05/2024 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2021
2	Asthma (Bronchial Asthma) 01/2024 - 01/2019
2	Hypersensitivity (Allergy) 11/2023 - 01/2023
2	Insulin Resistance 10/2023 - 01/2023
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 01/2023
2	Memory Disorders (Memory Loss) 08/2023 - 12/2018
2	Atrophy 01/2023 - 09/2004
2	Hyperthermia 01/2023 - 11/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 11/2022

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2004
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
10	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2016
10	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2013
8	Messenger RNA (mRNA)IBA 01/2024 - 09/2004
8	Therapeutic UsesIBA 01/2024 - 06/2004
7	Amyloid (Amyloid Fibrils)IBA 11/2023 - 11/2017
7	Long Noncoding RNAIBA 02/2022 - 08/2016
7	LuciferasesIBA 06/2008 - 03/2004
7	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 06/2008 - 09/2003
7	SurvivinIBA 11/2006 - 04/2004
6	Circular RNAIBA 01/2024 - 11/2019
6	Apolipoprotein E4IBA 11/2023 - 12/2020
6	Complement System Proteins (Complement)IBA 01/2023 - 01/2017
6	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 01/2018
5	IntegrinsIBA 03/2013 - 05/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2014
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 10/2003
4	adenovirus receptorIBA 02/2012 - 08/2002
3	LigandsIBA 01/2024 - 02/2012
3	Protein Isoforms (Isoforms)IBA 10/2023 - 01/2022
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2023 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2023
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 11/2004
3	CurcuminIBA 12/2022 - 12/2020
3	LipidsIBA 11/2022 - 05/2012
3	ElementsIBA 11/2022 - 10/2003
3	Antimicrobial Cationic PeptidesIBA 01/2021 - 12/2019
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2016
3	Secretory Leukocyte Peptidase InhibitorIBA 02/2005 - 11/2004
2	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2023
2	tetramethylene hemicyanineIBA 11/2023 - 01/2023
2	Alkaline PhosphataseIBA 11/2023 - 06/2021
2	Estrogens (Estrogen)FDA Link 11/2023 - 10/2016
2	Estrogen ReceptorsIBA 11/2023 - 10/2016
2	Apolipoprotein E3IBA 11/2023 - 01/2022
2	Immunoglobulin E (IgE)IBA 11/2023 - 01/2023
2	SphingolipidsIBA 11/2023 - 04/2021
2	ProteomeIBA 10/2023 - 01/2020
2	Gemcitabine FDA Link 10/2023 - 01/2021
2	Leucine (L-Leucine)FDA Link 10/2023 - 08/2022
2	sephin1IBA 09/2023 - 02/2023
2	Aspartic Acid (Aspartate)FDA Link 08/2023 - 02/2012
2	Biotin (Vitamin H)FDA Link 01/2023 - 01/2023
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 06/2021
2	AntioxidantsIBA 01/2023 - 06/2021
2	Caspase 3 (Caspase-3)IBA 01/2023 - 11/2022
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 05/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 11/2022

Therapy/Procedure

37	Therapeutics 11/2023 - 03/2002
6	Drug Therapy (Chemotherapy) 11/2023 - 06/2008
6	Immunotherapy 10/2023 - 01/2022
3	Transplantation 01/2023 - 10/2002
2	Aftercare (After-Treatment) 11/2023 - 04/2009
2	Neoadjuvant Therapy 06/2023 - 12/2012